TAKEDA VENTURES

takeda-ventures-logo

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. We are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance to entrepreneurs and early-stage companies driving concepts through clinical proof of concept. We also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Our goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.

#People #Financial #More

TAKEDA VENTURES

Social Links:

Industry:
Finance Financial Services Health Diagnostics Therapeutics

Founded:
2001-01-01

Status:
Active

Contact:
(619) 930-8400

Email Addresses:
[email protected]

Technology used in webpage:
CSC Global DNS CDNS Network


Current Employees Featured

michael-martin_image

Michael Martin
Michael Martin Head of Takeda Ventures, Inc. @ Takeda Ventures
Head of Takeda Ventures, Inc.
2015-01-01

Acquisitions List

Date Company Article Price
2021-10-27 GammaDelta Therapeutics GammaDelta Therapeutics acquired by Takeda Ventures N/A

Investments List

Date Company Article Money raised
2022-08-25 Zelluna Immunotherapy Takeda Ventures investment in Venture Round - Zelluna Immunotherapy N/A
2022-06-07 Code Biotherapeutics Takeda Ventures investment in Series A - Code Biotherapeutics 75 M USD
2022-04-14 Be Biopharma Takeda Ventures investment in Series B - Be Biopharma 130 M USD
2022-02-23 hC Bioscience Takeda Ventures investment in Series A - hC Bioscience 24 M USD
2022-02-07 Koneksa Health Takeda Ventures investment in Series C - Koneksa Health 45 M USD
2021-12-02 Integra Therapeutics Takeda Ventures investment in Seed Round - Integra Therapeutics 4.5 M EUR
2021-10-22 Egle Therapeutics Takeda Ventures investment in Series A - Egle Therapeutics 40 M EUR
2021-07-14 Turnstone Biologics Takeda Ventures investment in Series D - Turnstone Biologics 80 M USD
2021-06-14 Ribon Therapeutics Takeda Ventures investment in Series C - Ribon Therapeutics 65 M USD
2021-06-01 Transine Therapeutics Takeda Ventures investment in Seed Round - Transine Therapeutics 9.1 M GBP

More informations about "Takeda Ventures" on Search Engine